VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $130,476,000 | -73.7% | 4,961,079 | +1.6% | 3.55% | -68.5% |
| Q4 2015 | $496,239,000 | -28.6% | 4,881,835 | +25.2% | 11.26% | -25.2% |
| Q3 2015 | $695,441,000 | +14.4% | 3,898,648 | +42.5% | 15.04% | +13.6% |
| Q2 2015 | $607,946,000 | +97.4% | 2,736,647 | +27.2% | 13.24% | +50.4% |
| Q4 2014 | $307,955,000 | -34.4% | 2,151,874 | -39.8% | 8.80% | -40.9% |
| Q3 2014 | $469,302,000 | +30.5% | 3,576,998 | +25.5% | 14.87% | +10.6% |
| Q2 2014 | $359,590,000 | +12.2% | 2,851,175 | +17.3% | 13.45% | -1.6% |
| Q1 2014 | $320,473,000 | +28.1% | 2,430,955 | +14.1% | 13.67% | +4.8% |
| Q4 2013 | $250,215,000 | +12.5% | 2,131,300 | 0.0% | 13.05% | +5.2% |
| Q3 2013 | $222,359,000 | +12.0% | 2,131,300 | -7.6% | 12.40% | +14.5% |
| Q2 2013 | $198,587,000 | – | 2,307,000 | – | 10.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |